Press Releases - 2021-01-07

Date	Title	Company
07-Jan-2021	Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies	Theolytics
07-Jan-2021	Roche’s novel anti-TIGIT tiragolumab granted FDA Breakthrough Therapy Designation in combination with Tecentriq for PD-L1-high non-small cell lung cancer	Roche
07-Jan-2021	Risankizumab (SKYRIZI®) Phase 3 Results Demonstrate Improvements in Disease Activity Across Joint and Skin Symptoms Among Psoriatic Arthritis Patients	AbbVie
07-Jan-2021	Farxiga granted Priority Review in the US for the treatment of patients with chronic kidney disease	AstraZeneca
07-Jan-2021	Real-Time Bioprocess Raman Analyzer Market Growth Probability, Leading Vendors and Future Scenario up to 2020	MARKITWIRED
07-Jan-2021	Vascular Testing Devices Market Worldwide Prospects, Share, Crucial Players, Size & Forecast – 2030	MARKITWIRED
07-Jan-2021	LG Chem to Contribute to Global Polio Eradication with Eupolio™, the First Sabin Inactivated Polio Vaccine to Receive WHO Prequalification	Businesswire
07-Jan-2021	Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia	Businesswire
07-Jan-2021	Vividion Appoints Patty Allen, Experienced Financial Executive, as Acting Chief Financial Officer	Businesswire
07-Jan-2021	Teva et MedinCell annoncent des résultats positifs pour l'essai de Phase 3 visant à l’approbation d’un traitement injectable sous-cutanée à libération prolongée de Rispéridone pour les patients atteints de schizophrénie	Businesswire
07-Jan-2021	Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents	Businesswire
07-Jan-2021	PharmaEssentia Initiates Pivotal Trial of Ropeginterferon alfa-2b to Treat Essential Thrombocythemia	Businesswire
07-Jan-2021	CURE Pharmaceutical to Present at H.C. Wainwright BioConnect 2021 Virtual Conference	Businesswire
07-Jan-2021	Monte Rosa Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference	Businesswire
07-Jan-2021	Revance Provides Corporate Update and Anticipated Milestones for 2021	Businesswire
07-Jan-2021	Twist Bioscience Supplies Centers for Disease Control and Prevention with Custom SARS-CoV-2 Synthetic RNA Controls	Businesswire
07-Jan-2021	Standigm and SK Chemicals Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership	Businesswire
07-Jan-2021	Corinne Le Goff, Pharm.D. Will Join Moderna as Chief Commercial Officer on January 19	Businesswire
07-Jan-2021	McKesson Ventures Expands Portfolio Development Team and Invests in Market Research	Businesswire
07-Jan-2021	Ocular Therapeutix™ Promotes Michael Goldstein, MD, MBA, to President, Ophthalmology and Appoints Rabia Gurses Ozden, MD as Senior Vice President, Clinical Development	Businesswire